In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

ADMA Biologics Inc. Trade Record

NASDAQ:ADMA ADMA Biologics Inc stock gains 37.82% Exit Jan 31, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart ADMA Dec 22, 2017, priceSeries
About ADMA Biologics Inc

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. The company also operates source plasma collection facilities in Norcross and Marietta, Georgia. ADMA Biologics, Inc. was founded in 2004 and is based in Ramsey, New Jersey.

Trade Information
Trade Type
LONG
ReliabilityScore™
97.44
Entry Date
Dec 22, 2017
Entry Price
2.64
Sell Date
Jan 31, 2018
Sell Price
3.64
Net Gain
37.82%
Hold Time
25 Trading Days